Crossmark

Determining the cytotoxicity of the Minimum Inhibitory Concentration (MIC) of silver and zinc oxide nanoparticles in ESBL and carbapenemase producing Proteus mirabilis isolated from clinical samples in Shiraz, Southwest Iran

Crossref DOI link: https://doi.org/10.1186/s13104-023-06402-2

Published Online: 2024-01-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kakian, Farshad

Mirzaei, Esmaeil

Moattari, Afagh

Takallu, Sara

Bazargani, Abdollah http://orcid.org/0000-0001-6430-0596
License Information

Text and Data Mining valid from 2024-01-29

Version of Record valid from 2024-01-29
More Information

Article History

Received: 13 October 2022

Accepted: 18 June 2023

First Online: 29 January 2024

Declarations

:

: This study was approved by the Ethics Committee of Shiraz University of Medical Sciences (Ethics code: <i>IR.SUMS.REC.1400.803)</i>. All the participants signed the informed consent. For people under 16 years of age, informed consent was obtained from their parents or legal guardians. We followed all the ethical principles of the World Medical Association Declaration of Helsinki for medical research involving human subjects. Participants were ensured that their data will be processed by Iran’s data protection laws, which ensure their confidentiality.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below